Title: Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults
Speaker: P.J. (Paul) Wichgers Schreur, Wageningen Bioveterinary Research, Netherlands
Time: 11:00 EST | 17:00 CET
The ISV is a global not-for-profit organization that aims to encourage, establish, and promote the development and use of vaccines to prevent and control infectious and non-infectious diseases in animals and humans.